Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations from a Phase I/II Trial Article

ESI Most Cited Paper Industry Collaboration

cited authors

  • Riely, Gregory J.; Neal, Joel W.; Camidge, D. Ross; Spira, Alexander, I; Piotrowska, Zofia; Costa, Daniel B.; Tsao, Anne S.; Patel, Jyoti D.; Gadgeel, Shirish M.; Bazhenova, Lyudmila; Zhu, Viola W.; West, Howard L.; Mekhail, Tarek; Gentzler, Ryan D.; Nguyen, Danny; Vincent, Sylvie; Zhang, Steven; Lin, Jianchang; Bunn, Veronica; Jin, Shu; Li, Shuanglian; Janne, Pasi A.

authors

Publication Date

  • July 1, 2021

webpage

published in

category

start page

  • 1688

end page

  • 1699

volume

  • 11

issue

  • 7